GlassScriptPhysician profile
Taylor P Johnson
NPI 1124559315
$2,491.61
in general payments reported to CMS, 2019-2025
18 companies · $2,003 in 2025
The $2,003 reported for 2025 was more than what 94% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $30.01 · 2024: $458 · 2025: $2,003.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,283 · Food and Beverage: $1,079 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,283.48 |
| Food and Beverage | $1,079.12 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $1,525.06 | 2025 | Gelpoint V-Path |
| Astellas Pharma US INC | $174.51 | 2024-2025 | Veozah |
| Lilly USA, LLC | $133.36 | 2025 | Zepbound |
| Exeltis, USA INC. | $126.70 | 2024-2025 | Slynd |
| Daiichi Sankyo INC. | $68.45 | 2024 | Injectafer |
| Coopersurgical, INC. | $61.75 | 2024-2025 | Paragard T 380a |
| Organon LLC | $60.41 | 2024-2025 | Nexplanon |
| Mayne Pharma Commercial LLC | $57.95 | 2025 | |
| Exact Sciences Corporation | $51.38 | 2024-2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $41.86 | 2024-2025 | Wegovy |
| Abbvie INC. | $31.84 | 2024 | |
| Ge Healthcare | $30.01 | 2021 | |
| Shield Therapeutics INC | $28.89 | 2025 | |
| Sumitomo Pharma America, INC. | $25.26 | 2025 | Myfembree |
| Hologic Sales and Service, LLC | $20.14 | 2024 | Aptima |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $19.81 | 2025 | |
| Biogen, INC. | $18.24 | 2025 | Zurzuvae |
| Dexcom, INC. | $15.99 | 2025 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.